首页 > 最新文献

Annales chirurgiae et gynaecologiae. Supplementum最新文献

英文 中文
Induction of new bone by allogeneic demineralized bone matrix combined to bioactive glass composite in the rat. 异基因脱矿骨基质联合生物活性玻璃复合材料诱导大鼠新生骨。
K J Pajamäki, O H Andersson, T S Lindholm, K H Karlsson, A Yli-Urpo

Allogeneic diaphyseal demineralized bone matrix (DBM) cylinders containing bioactive glass rods were implanted for 4 and 8 weeks in the abdominal muscle wall of rats. DBM without glass served as control. The results suggest that new bone induction by DBM was accelerated by the presence of bioactive glass implants. However, the bone formation induced by DBM on the glass surface was relatively small. The biocompatibility of the glass was verified by the absence of adverse cellular reactions in the interface region between glass and bone. The method used provides a simple and fast means of exploring the characteristics of potential bone substitutes.

将含有生物活性玻璃棒的同种异体干脱矿骨基质(DBM)圆柱体植入大鼠腹肌壁4周和8周。不加玻璃的DBM作为对照。结果表明,生物活性玻璃植入物的存在加速了DBM诱导新骨的速度。而DBM在玻璃表面诱导的骨形成相对较小。通过在玻璃和骨之间的界面区域没有不良细胞反应,证实了玻璃的生物相容性。所使用的方法为探索潜在骨替代物的特性提供了一种简单快速的方法。
{"title":"Induction of new bone by allogeneic demineralized bone matrix combined to bioactive glass composite in the rat.","authors":"K J Pajamäki,&nbsp;O H Andersson,&nbsp;T S Lindholm,&nbsp;K H Karlsson,&nbsp;A Yli-Urpo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Allogeneic diaphyseal demineralized bone matrix (DBM) cylinders containing bioactive glass rods were implanted for 4 and 8 weeks in the abdominal muscle wall of rats. DBM without glass served as control. The results suggest that new bone induction by DBM was accelerated by the presence of bioactive glass implants. However, the bone formation induced by DBM on the glass surface was relatively small. The biocompatibility of the glass was verified by the absence of adverse cellular reactions in the interface region between glass and bone. The method used provides a simple and fast means of exploring the characteristics of potential bone substitutes.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"207 ","pages":"137-43"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19145981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cavernous auto-injection therapy with prostaglandin E1. 前列腺素E1海绵体自体注射治疗。
H Nisén

During 1990-1992, 176 consecutive patients (aged 18-83 years, mean 53 years) with erectile dysfunction were personally investigated by the author in the private office setting at Eira Hospital. Pharmacotesting with 20 micrograms prostaglandin was positive in 89 of 138 patients (64%) tested. Eleven per cent of the patients complained of pain during erection. Of 131 patients, who initially were offered auto-injections as a primary treatment modality, 99 (76%) began the therapy. Seventy-four per cent of the patients continued auto-injections after three months. The overall efficacy of prostaglandin E1 to induce adequate erections for sexual intercourse was estimated to be 71%. One prolonged erection without medical intervention and no penile fibrotic lesions were recorded. In conclusion, cavernous auto-injection therapy with prostaglandin E1 is a well accepted, effective and safe treatment alternative in psychogenic as well as organic impotence. Every impotent patient should be informed of this therapy.

1990-1992年期间,作者在Eira医院的私人办公室对176名患有勃起功能障碍的连续患者(年龄18-83岁,平均53岁)进行了亲自调查。138例患者中有89例(64%)在20微克前列腺素药物试验中呈阳性。11%的患者抱怨勃起时疼痛。在131名患者中,最初将自动注射作为主要治疗方式,99名(76%)患者开始了治疗。74%的患者在三个月后继续进行自动注射。前列腺素E1诱导性交时勃起的总有效率估计为71%。一例无药物干预的长时间勃起,无阴茎纤维化病变记录。综上所述,前列腺素E1海绵体自体注射治疗心因性和器质性阳痿是一种被广泛接受、有效和安全的治疗方法。每个阳痿患者都应该被告知这种疗法。
{"title":"Cavernous auto-injection therapy with prostaglandin E1.","authors":"H Nisén","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>During 1990-1992, 176 consecutive patients (aged 18-83 years, mean 53 years) with erectile dysfunction were personally investigated by the author in the private office setting at Eira Hospital. Pharmacotesting with 20 micrograms prostaglandin was positive in 89 of 138 patients (64%) tested. Eleven per cent of the patients complained of pain during erection. Of 131 patients, who initially were offered auto-injections as a primary treatment modality, 99 (76%) began the therapy. Seventy-four per cent of the patients continued auto-injections after three months. The overall efficacy of prostaglandin E1 to induce adequate erections for sexual intercourse was estimated to be 71%. One prolonged erection without medical intervention and no penile fibrotic lesions were recorded. In conclusion, cavernous auto-injection therapy with prostaglandin E1 is a well accepted, effective and safe treatment alternative in psychogenic as well as organic impotence. Every impotent patient should be informed of this therapy.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"69-73"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19278938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors of advanced prostatic carcinoma. 晚期前列腺癌的预后因素分析。
O Lukkarinen, K Lehikoinen

Eighty-two patients with advanced prostatic carcinoma were treated with a long-acting luteinizing hormone releasing hormone (LHRH) agonist (Zoladex depot, Zeneca Pharmaceuticals, England). The outcome of the treatment was monitored on the basis of the following prognostic factors: local stage, number of bone metastases, histological differentiation grade and prostate-specific acid phosphatase (PAP), alkaline phosphatase (AF) and testosterone levels. The patients were followed-up until disease progression or until death. The mean weight of the prostate decreased from 48.1 g to 17.4 g (P < 0.00001) during the first year of treatment. Statistically there was a significant difference in regard to appearance of progression between different clinical stages (P < 0.00001). The prognosis was poorest in patients with more than 10 metastases at the primary stage. If the PAP level was initially higher (over 20 micrograms/L), the prognosis was very poor. Statistically there was a significant difference between the high PAP level and the slightly elevated or normal PAP (P < 0.02 and P < 0.005, respectively). Alkaline phosphatase (AF) appeared to be a good prognostic factor. The prognosis was particularly poor, if the AF level exceeded 1000 U/L (P < 0.00001 and P < 0.05, compared with normal AP and slightly elevated AP level, respectively). Surprisingly, a high pre-treatment testosterone level worsened the prognosis during the LHRH agonist treatment (P < 0.01, compared to patients with normal testosterone level). This is a new finding and controversial to the findings reported before.

采用长效黄体生成素释放激素(LHRH)激动剂(Zoladex depot, Zeneca Pharmaceuticals, England)治疗82例晚期前列腺癌患者。根据以下预后因素监测治疗结果:局部分期、骨转移数量、组织学分化等级、前列腺特异性酸性磷酸酶(PAP)、碱性磷酸酶(AF)和睾酮水平。对患者进行随访,直至疾病进展或死亡。在治疗的第一年,前列腺的平均重量从48.1 g下降到17.4 g (P < 0.00001)。不同临床分期的进展情况差异有统计学意义(P < 0.00001)。原发期超过10个转移灶的患者预后最差。如果PAP初始水平较高(超过20微克/升),则预后很差。高PAP与轻度升高或正常PAP差异有统计学意义(P < 0.02、P < 0.005)。碱性磷酸酶(AF)似乎是一个良好的预后因素。当AF水平超过1000 U/L时(P < 0.00001, P < 0.05,分别与AP正常和AP轻度升高相比),预后尤其差。令人惊讶的是,治疗前高睾酮水平恶化了LHRH激动剂治疗期间的预后(P < 0.01,与睾酮水平正常的患者相比)。这是一项新发现,与之前报道的发现相比存在争议。
{"title":"Prognostic factors of advanced prostatic carcinoma.","authors":"O Lukkarinen,&nbsp;K Lehikoinen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Eighty-two patients with advanced prostatic carcinoma were treated with a long-acting luteinizing hormone releasing hormone (LHRH) agonist (Zoladex depot, Zeneca Pharmaceuticals, England). The outcome of the treatment was monitored on the basis of the following prognostic factors: local stage, number of bone metastases, histological differentiation grade and prostate-specific acid phosphatase (PAP), alkaline phosphatase (AF) and testosterone levels. The patients were followed-up until disease progression or until death. The mean weight of the prostate decreased from 48.1 g to 17.4 g (P < 0.00001) during the first year of treatment. Statistically there was a significant difference in regard to appearance of progression between different clinical stages (P < 0.00001). The prognosis was poorest in patients with more than 10 metastases at the primary stage. If the PAP level was initially higher (over 20 micrograms/L), the prognosis was very poor. Statistically there was a significant difference between the high PAP level and the slightly elevated or normal PAP (P < 0.02 and P < 0.005, respectively). Alkaline phosphatase (AF) appeared to be a good prognostic factor. The prognosis was particularly poor, if the AF level exceeded 1000 U/L (P < 0.00001 and P < 0.05, compared with normal AP and slightly elevated AP level, respectively). Surprisingly, a high pre-treatment testosterone level worsened the prognosis during the LHRH agonist treatment (P < 0.01, compared to patients with normal testosterone level). This is a new finding and controversial to the findings reported before.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"206 ","pages":"9-13"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19279521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative candidiasis. 术后念珠菌病。
A Rantala

Candida species are important opportunistic pathogens in compromised hosts, such as patients recovering from major abdominal surgery. The incidence, pathogenesis, diagnosis and prognosis of postoperative candidiasis were studied in a general surgical department. Transplantation surgery was not included. The mean incidence of postoperative candidiasis in abdominal surgery was 6.2 per 1000 laparotomies. The estimated incidence was higher during the years 1987-1992 than 1981-1986. Postoperative candidiasis was most often encountered in patients undergoing surgery of the small intestine or pancreas. These patients had certain typical features: a long hospitalization before signs, central catheterization, parenteral nutrition, prolonged antibiotic therapy and reoperations; malignancy, corticosteroid or immunosuppressive therapy were uncommon. Multiple blood cultures during reoperations were not found to yield Candida; hence, hematogenous dissemination from the gut was not seen. The prognosis of postoperative candidiasis was poor: the infection mortality was 70-79% and significantly higher than in patients with postoperative bacterial septicemia. Early therapeutic measures resulted in a significantly better prognosis as compared to delayed treatment. Arabinitol was found a specific marker of candidiasis, but because sequential samples were needed for adequate sensitivity, a single arabinitol concentration determination in the beginning of the disease was not useful. Febrile patients who had Candida in any sample during the first postoperative week had a poor prognosis. The results show that patients with candidiasis have typical clinical features that facilitate suspicion. Antifungal therapy is mandatory and must be started as soon as a suspicion of candidiasis has risen, before the results of specific laboratory tests are available.

念珠菌是受损宿主(如腹部大手术恢复期患者)中重要的机会致病菌。对某普外科术后念珠菌病的发病率、发病机制、诊断及预后进行了研究。移植手术不包括在内。腹部手术术后念珠菌病的平均发病率为6.2 / 1000。1987-1992年的估计发病率高于1981-1986年。术后念珠菌病最常见于小肠或胰腺手术患者。这些患者具有一定的典型特征:住院时间长,出现体征,中心置管,肠外营养,抗生素治疗时间长,再手术;恶性肿瘤、皮质类固醇或免疫抑制治疗不常见。再手术时多次血培养未发现念珠菌;因此,未见来自肠道的血液播散。术后念珠菌病预后较差,感染死亡率为70-79%,明显高于术后细菌性败血症患者。与延迟治疗相比,早期治疗措施可显著改善预后。阿拉伯糖醇被发现是念珠菌病的特异性标记物,但由于需要连续取样以获得足够的灵敏度,因此在疾病开始时单一测定阿拉伯糖醇浓度是无用的。术后第一周任何样本中有念珠菌的发热患者预后较差。结果表明,念珠菌病患者具有典型的临床特征,易于怀疑。抗真菌治疗是强制性的,一旦怀疑有念珠菌病,必须在获得特定实验室检测结果之前立即开始。
{"title":"Postoperative candidiasis.","authors":"A Rantala","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Candida species are important opportunistic pathogens in compromised hosts, such as patients recovering from major abdominal surgery. The incidence, pathogenesis, diagnosis and prognosis of postoperative candidiasis were studied in a general surgical department. Transplantation surgery was not included. The mean incidence of postoperative candidiasis in abdominal surgery was 6.2 per 1000 laparotomies. The estimated incidence was higher during the years 1987-1992 than 1981-1986. Postoperative candidiasis was most often encountered in patients undergoing surgery of the small intestine or pancreas. These patients had certain typical features: a long hospitalization before signs, central catheterization, parenteral nutrition, prolonged antibiotic therapy and reoperations; malignancy, corticosteroid or immunosuppressive therapy were uncommon. Multiple blood cultures during reoperations were not found to yield Candida; hence, hematogenous dissemination from the gut was not seen. The prognosis of postoperative candidiasis was poor: the infection mortality was 70-79% and significantly higher than in patients with postoperative bacterial septicemia. Early therapeutic measures resulted in a significantly better prognosis as compared to delayed treatment. Arabinitol was found a specific marker of candidiasis, but because sequential samples were needed for adequate sensitivity, a single arabinitol concentration determination in the beginning of the disease was not useful. Febrile patients who had Candida in any sample during the first postoperative week had a poor prognosis. The results show that patients with candidiasis have typical clinical features that facilitate suspicion. Antifungal therapy is mandatory and must be started as soon as a suspicion of candidiasis has risen, before the results of specific laboratory tests are available.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"205 ","pages":"1-52"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19321294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts. The Scandinavian Surgical Society, 44th Congress. Helsinki, June 15-17, 1989. 摘要。斯堪的纳维亚外科学会,第44届大会。赫尔辛基,1989年6月15日至17日。
{"title":"Abstracts. The Scandinavian Surgical Society, 44th Congress. Helsinki, June 15-17, 1989.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"204 ","pages":"1-59"},"PeriodicalIF":0.0,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13876063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progesterone support of the luteal phase in in vitro fertilization program--a hazard? 体外受精项目中黄体期黄体酮的支持——危害?
V Nikkanen, P Katainen, O Piiroinen

To study the effect of progesterone support of the luteal phase in a stimulated cycle a subgroup of our IVF patients was treated with progesterone vaginal suppositoria. The treatment was initiated on the aspiration day. There was no significant difference in the pregnancy or abortion rate between the control group and the gestagen therapy group. However, it seems that progesterone support may increase the pregnancy rate but also the rate of spontaneous abortion. This suggests that the effective and early started progesterone supplementation of the luteal phase may cause the implantation of abnormal nonviable embryos.

为了研究黄体酮在刺激周期中对黄体期的支持作用,我们的试管婴儿患者亚组接受了黄体酮阴道栓剂治疗。于吸痰当日开始治疗。对照组和孕激素治疗组的妊娠率和流产率均无显著差异。然而,似乎黄体酮支持可能会增加怀孕率,但也会增加自然流产率。提示黄体期早期有效补充黄体酮可能导致异常无活胚胎的着床。
{"title":"Progesterone support of the luteal phase in in vitro fertilization program--a hazard?","authors":"V Nikkanen,&nbsp;P Katainen,&nbsp;O Piiroinen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To study the effect of progesterone support of the luteal phase in a stimulated cycle a subgroup of our IVF patients was treated with progesterone vaginal suppositoria. The treatment was initiated on the aspiration day. There was no significant difference in the pregnancy or abortion rate between the control group and the gestagen therapy group. However, it seems that progesterone support may increase the pregnancy rate but also the rate of spontaneous abortion. This suggests that the effective and early started progesterone supplementation of the luteal phase may cause the implantation of abnormal nonviable embryos.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"202 ","pages":"42-4"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14602416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abdominal hysterectomy versus supravaginal uterine amputation: psychic factors. 腹部子宫切除术与阴道上子宫截肢:心理因素。
P Kilkku, V Lehtinen, T Hirvonen, M Grönroos

In the present study, the psychic complaints after abdominal hysterectomy (n = 105) and supravaginal uterine amputation (n = 107) are investigated. The first author interviewed personally all the subjects preoperatively and 6 weeks, 6 months, 1 year and 3 years postoperatively. The proportion of subjects without psychic symptoms increased from 49.5% to 67.7% in the hysterectomy group (p less than 0.01) and from 53.3% to 76.8% in the amputation group (p less than 0.001). The difference between the groups at 3 years phase was significant (p less than 0.01). From the single symptoms, nervousness or irritability and depression, decreased during the follow-up period significantly in the amputation group but not in the hysterectomy group. The results clearly indicate that the view of an increased risk for depression or other psychic complications after removal of the uterus should be revised. On the other hand, the results support our earlier findings that supravaginal uterine amputation is still an applicable method in benign conditions.

本研究调查了腹部子宫切除术(105例)和阴道上子宫切除术(107例)术后的心理疾患。第一作者于术前及术后6周、6个月、1年、3年亲自对所有受试者进行访谈。无精神症状的受试者比例在子宫切除术组从49.5%上升到67.7% (p < 0.01),在截肢组从53.3%上升到76.8% (p < 0.001)。3年时各组间差异有统计学意义(p < 0.01)。从单一症状来看,神经紧张或烦躁和抑郁在截肢组随访期间明显减少,而子宫切除术组则没有。结果清楚地表明,子宫切除后抑郁或其他精神并发症风险增加的观点应该改变。另一方面,结果支持我们早期的发现,阴道上子宫截肢仍然是一种适用于良性条件的方法。
{"title":"Abdominal hysterectomy versus supravaginal uterine amputation: psychic factors.","authors":"P Kilkku,&nbsp;V Lehtinen,&nbsp;T Hirvonen,&nbsp;M Grönroos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the present study, the psychic complaints after abdominal hysterectomy (n = 105) and supravaginal uterine amputation (n = 107) are investigated. The first author interviewed personally all the subjects preoperatively and 6 weeks, 6 months, 1 year and 3 years postoperatively. The proportion of subjects without psychic symptoms increased from 49.5% to 67.7% in the hysterectomy group (p less than 0.01) and from 53.3% to 76.8% in the amputation group (p less than 0.001). The difference between the groups at 3 years phase was significant (p less than 0.01). From the single symptoms, nervousness or irritability and depression, decreased during the follow-up period significantly in the amputation group but not in the hysterectomy group. The results clearly indicate that the view of an increased risk for depression or other psychic complications after removal of the uterus should be revised. On the other hand, the results support our earlier findings that supravaginal uterine amputation is still an applicable method in benign conditions.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"202 ","pages":"62-7"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14603176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individually modified treatment of invasive squamous cell vulvar cancer: 10-year experience. 侵袭性鳞状细胞外阴癌的个体化改良治疗:10年经验。
J Mäkinen, T Salmi, M Grönroos

In 63 patients with invasive vulvar squamous cell cancer treatment was individualized according to patient tolerance: surgery was less mutilating than conventionally, while radio and chemotherapy was given judiciously. The overall 5-year crude survival rate was 43.5%, while the most common treatment (bleomycin, electroexcision and irradiation) had a 5-year survival rate of 55.2%. The rate of complications was low, although most of the patients were of advanced age and had intercurrent diseases. Although the therapy we applied most often yielded moderately satisfactory results it would appear according to the literature that marginal tumor excision accompanied with inguinal lymph node dissection could still improve patient outcome. This strategy could also include predictive testing of sensitivity of the tumors to cytostatics.

在63例浸润性外阴鳞状细胞癌患者中,根据患者的耐受性进行个体化治疗:手术比常规治疗更具致残性,同时明智地给予放疗和化疗。总体5年粗生存率为43.5%,而最常见的治疗方法(博来霉素、电切和放疗)的5年生存率为55.2%。并发症的发生率较低,但大多数患者年龄较大且有并发疾病。虽然我们所采用的治疗方法通常产生了中等满意的结果,但根据文献显示,边缘肿瘤切除合并腹股沟淋巴结清扫仍然可以改善患者的预后。该策略还可以包括肿瘤对细胞抑制剂敏感性的预测测试。
{"title":"Individually modified treatment of invasive squamous cell vulvar cancer: 10-year experience.","authors":"J Mäkinen,&nbsp;T Salmi,&nbsp;M Grönroos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In 63 patients with invasive vulvar squamous cell cancer treatment was individualized according to patient tolerance: surgery was less mutilating than conventionally, while radio and chemotherapy was given judiciously. The overall 5-year crude survival rate was 43.5%, while the most common treatment (bleomycin, electroexcision and irradiation) had a 5-year survival rate of 55.2%. The rate of complications was low, although most of the patients were of advanced age and had intercurrent diseases. Although the therapy we applied most often yielded moderately satisfactory results it would appear according to the literature that marginal tumor excision accompanied with inguinal lymph node dissection could still improve patient outcome. This strategy could also include predictive testing of sensitivity of the tumors to cytostatics.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"202 ","pages":"68-71"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14603177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The subrenal capsule assay and gynecological cancer: five years of experience. 肾下包膜试验与妇科癌症:5年经验。
J Mäenpää, L Kangas, K O Söderström, M Grönroos

From 1982 through 1986 the subrenal capsule assay (SRCA) was used to test the sensitivity of 304 gynecological malignant tumors to cytotoxic drug combinations. Most of the tumors were ovarian cancers. Ninety-five percent of the assays were evaluable. Histological and ultrastructural studies were performed on transplants derived from ovarian cancers. Besides cytotoxic drugs, the activity of interferons was also studied by SRCA. Clinical comparisons were available in 43 patients with advanced disease; the predictive accuracy rate of the assay was 77%. The histological, ultrastructural and clinical studies indicated that SRCA is a reliable predictive test, which aids in the selection of proper therapy for individual patients.

从1982年到1986年,肾下包膜试验(SRCA)被用于检测304例妇科恶性肿瘤对细胞毒性药物组合的敏感性。大多数肿瘤是卵巢癌。95%的检测是可评价的。对卵巢癌移植瘤进行组织学和超微结构研究。除了细胞毒性药物外,SRCA还研究了干扰素的活性。43例晚期患者进行了临床比较;该方法预测准确率为77%。组织学、超微结构和临床研究表明,SRCA是一种可靠的预测试验,有助于个体患者选择合适的治疗方法。
{"title":"The subrenal capsule assay and gynecological cancer: five years of experience.","authors":"J Mäenpää,&nbsp;L Kangas,&nbsp;K O Söderström,&nbsp;M Grönroos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>From 1982 through 1986 the subrenal capsule assay (SRCA) was used to test the sensitivity of 304 gynecological malignant tumors to cytotoxic drug combinations. Most of the tumors were ovarian cancers. Ninety-five percent of the assays were evaluable. Histological and ultrastructural studies were performed on transplants derived from ovarian cancers. Besides cytotoxic drugs, the activity of interferons was also studied by SRCA. Clinical comparisons were available in 43 patients with advanced disease; the predictive accuracy rate of the assay was 77%. The histological, ultrastructural and clinical studies indicated that SRCA is a reliable predictive test, which aids in the selection of proper therapy for individual patients.</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"202 ","pages":"83-7"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13590691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstetric care, pregnancy risk factors and perinatal outcome in the province of Uusimaa, Finland, in 1980-1981. 1980-1981年芬兰乌西马省的产科护理、妊娠风险因素和围产期结果。
T Hakala

The study was carried out in order to learn about the present state of obstetric care and perinatal outcome in the province of Uusimaa, Finland. The material consisted of 29,061 pregnant women, including 313 multiple pregnancies and 29,374 newborn infants born in the years 1980 and 1981. The information gathered was mostly retrospective. The overall frequency of LBW children was 3.9 percent, of very LBW children 0.8, of preterm children 5.8, of very preterm children 0.7, and of post-term children 4.7 percent. The overall frequency of neonatal transfers to a pediatric ward was 8.6 percent. Centralization of high risk deliveries has increased in Uusimaa since 1975, as judged by the frequencies of LBW children born at the two largest delivery units and four district hospitals. Almost 95 percent of mothers-to-be began their antenatal classes before 16 weeks of gestation. Late admission to antenatal care after week 15 was an independent risk factor for unfavorable pregnancy outcome. The cesarean section rate was 16.5 percent. The frequencies were highest at the State Maternity Hospital (19.7%) and Helsinki University Central Hospital (18.2%). The frequency varied largely in district hospitals (5.9-16.3%). This resulted partly from different indications for cesarean sections in these hospitals. The mean age of the parturients was 28.5 years. The best pregnancy outcome was observed in women aged 25-29 years. Almost half of the parturients were primiparous, and only 4.0 percent were quadri- or grand multiparous. Secundiparous women had the best pregnancy outcome. Terti-parity or more was not a risk factor per se; the difference in the frequency of unfavorable outcome between secundiparas and terti-paras or more disappeared after those with unsuccessful histories were excluded, while the difference still remained significant between primi- and secundiparas. Of all pregnant women, 23 percent had experienced one and 6.4 percent several spontaneous or legally induced abortions. The effect of the number of abortions on the frequency of preterm and very preterm deliveries was linear both in singleton and multiple pregnancies. Almost 70 percent of the parturients belonged to the two highest social classes and 86 percent were married. Children of married women from higher social classes had the best perinatal outcome. Unmarried women from lower social classes more often had 'behavioral' risk factors--they were more often heavy smokers, were uncertain about the dates, had had two or more abortions and neglected maternity care.(ABSTRACT TRUNCATED AT 400 WORDS)

进行这项研究是为了了解芬兰乌西马省的产科护理和围产期结果的现状。该资料包括29,061名孕妇,其中包括313名多胎妊娠和29,374名出生于1980年和1981年的新生儿。收集的信息大多是回顾性的。低体重儿童的总体发生率为3.9%,重度低体重儿童为0.8%,早产儿为5.8,重度早产儿童为0.7%,足月后儿童为4.7%。新生儿转到儿科病房的总体频率为8.6%。根据在两个最大的分娩单位和四个地区医院出生的低出生体重婴儿的频率判断,自1975年以来,乌干达高风险分娩的集中化程度有所提高。几乎95%的准妈妈在怀孕16周之前就开始了产前课程。第15周后延迟接受产前护理是不良妊娠结局的独立危险因素。剖宫产率为16.5%。发病率最高的是国立妇产医院(19.7%)和赫尔辛基大学中心医院(18.2%)。地区医院的频率差异很大(5.9-16.3%)。造成这种情况的部分原因是这些医院剖宫产手术的适应症不同。产妇平均年龄28.5岁。25-29岁的女性妊娠结局最好。几乎一半的产妇是初产,只有4.0%是四胎或大胎。二次生育妇女的妊娠结局最好。三等分或更多分本身并不是一个风险因素;排除有不成功病史的患者后,二胎和三胎及以上患者不良结局发生频率的差异消失,而一胎和二胎之间的差异仍然显著。在所有孕妇中,23%的人经历过一次,6.4%的人经历过几次自然流产或合法人工流产。在单胎和多胎妊娠中,流产次数对早产和极早产分娩频率的影响是线性的。近70%的孕妇属于两个最高的社会阶层,86%的孕妇已婚。社会阶层较高的已婚妇女的孩子围产期结局最好。社会阶层较低的未婚女性往往有“行为上的”风险因素——她们通常是重度吸烟者,不确定怀孕日期,有过两次或两次以上的堕胎经历,并且忽视了产科护理。(摘要删节为400字)
{"title":"Obstetric care, pregnancy risk factors and perinatal outcome in the province of Uusimaa, Finland, in 1980-1981.","authors":"T Hakala","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The study was carried out in order to learn about the present state of obstetric care and perinatal outcome in the province of Uusimaa, Finland. The material consisted of 29,061 pregnant women, including 313 multiple pregnancies and 29,374 newborn infants born in the years 1980 and 1981. The information gathered was mostly retrospective. The overall frequency of LBW children was 3.9 percent, of very LBW children 0.8, of preterm children 5.8, of very preterm children 0.7, and of post-term children 4.7 percent. The overall frequency of neonatal transfers to a pediatric ward was 8.6 percent. Centralization of high risk deliveries has increased in Uusimaa since 1975, as judged by the frequencies of LBW children born at the two largest delivery units and four district hospitals. Almost 95 percent of mothers-to-be began their antenatal classes before 16 weeks of gestation. Late admission to antenatal care after week 15 was an independent risk factor for unfavorable pregnancy outcome. The cesarean section rate was 16.5 percent. The frequencies were highest at the State Maternity Hospital (19.7%) and Helsinki University Central Hospital (18.2%). The frequency varied largely in district hospitals (5.9-16.3%). This resulted partly from different indications for cesarean sections in these hospitals. The mean age of the parturients was 28.5 years. The best pregnancy outcome was observed in women aged 25-29 years. Almost half of the parturients were primiparous, and only 4.0 percent were quadri- or grand multiparous. Secundiparous women had the best pregnancy outcome. Terti-parity or more was not a risk factor per se; the difference in the frequency of unfavorable outcome between secundiparas and terti-paras or more disappeared after those with unsuccessful histories were excluded, while the difference still remained significant between primi- and secundiparas. Of all pregnant women, 23 percent had experienced one and 6.4 percent several spontaneous or legally induced abortions. The effect of the number of abortions on the frequency of preterm and very preterm deliveries was linear both in singleton and multiple pregnancies. Almost 70 percent of the parturients belonged to the two highest social classes and 86 percent were married. Children of married women from higher social classes had the best perinatal outcome. Unmarried women from lower social classes more often had 'behavioral' risk factors--they were more often heavy smokers, were uncertain about the dates, had had two or more abortions and neglected maternity care.(ABSTRACT TRUNCATED AT 400 WORDS)</p>","PeriodicalId":75497,"journal":{"name":"Annales chirurgiae et gynaecologiae. Supplementum","volume":"203 ","pages":"1-83"},"PeriodicalIF":0.0,"publicationDate":"1987-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14605091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales chirurgiae et gynaecologiae. Supplementum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1